Combining Stellate Ganglion Block With Prolonged Exposure for PTSD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Combining Stellate Ganglion Block With Prolonged Exposure for PTSD — Stella

Home/Stress Disorders, Post-Traumatic/

View on ClinicalTrials.gov

Recruiting

Back to Stress Disorders, Post-Traumatic trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

Carl R. Darnall Army Medical Center, Fort Hood, Texas

University of Texas Health Science Center at San Antonio, San Antonio, Texas

Key details

Phase

Safety & dosing

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

United States Department of Defense

Enrollment target

~140 participants

Started

February 2024

Primary completion

March 2027

Age range

18 Years – 65 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.